Allogene Therapeutics ALLO
NASDAQ ALLO
$1.25 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

Allogene Therapeutics (ALLO) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Allogene Therapeutics 431.68 Mn -670.21 Mn - 36.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.31 Mn
Mar 31, 2026 72.12 Mn
Dec 31, 2025 61.99 Mn
Sep 30, 2025 61.91 Mn
Jun 30, 2025 53.80 Mn
Mar 31, 2025 56.50 Mn
Dec 31, 2024 102.17 Mn
Sep 30, 2024 115.20 Mn
Jun 30, 2024 117.22 Mn
Mar 31, 2024 103.27 Mn
Dec 31, 2023 136.34 Mn
Sep 30, 2023 165.16 Mn
Jun 30, 2023 152.87 Mn
Mar 31, 2023 149.06 Mn
Dec 31, 2022 99.08 Mn
Sep 30, 2022 74.58 Mn
Jun 30, 2022 117.12 Mn
Mar 31, 2022 68.68 Mn
Dec 31, 2021 82.54 Mn
Sep 30, 2021 161.78 Mn
API Access

Allogene Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ALLO&period=max&api_key=YOUR_API_KEY